William P. Forbes

CIK: 0001314760

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)19 (32.8%)

Derivative conversions

Awards (A)20 (34.5%)

Compensation grants

Other (G, F, J, C, D, …)19 (32.8%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

HRTX

HERON THERAPEUTICS, INC. /DE/

Officer

XAIR

Beyond Air, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (58 total)

HRTX
HERON THERAPEUTICS, INC. /DE/
Oct 19, 2026
Exercise(M)
Direct
3.9K shares-
HRTX
HERON THERAPEUTICS, INC. /DE/
Oct 19, 2026
Tax Payment(F)
Direct
1.1K shares at avg. $0.36$396.72
HRTX
HERON THERAPEUTICS, INC. /DE/
Jul 31, 2026
Tax Payment(F)
Direct
3.3K shares at avg. $0.50$2K
HRTX
HERON THERAPEUTICS, INC. /DE/
Jul 31, 2026
Exercise(M)
Direct
11.7K shares-
HRTX
HERON THERAPEUTICS, INC. /DE/
Jul 30, 2026
Exercise(M)
Direct
11.8K shares-
HRTX
HERON THERAPEUTICS, INC. /DE/
Jul 30, 2026
Tax Payment(F)
Direct
3.3K shares at avg. $0.50$2K
HRTX
HERON THERAPEUTICS, INC. /DE/
Jul 19, 2026
Exercise(M)
Direct
3.9K shares-
HRTX
HERON THERAPEUTICS, INC. /DE/
Jul 19, 2026
Tax Payment(F)
Direct
1.1K shares at avg. $0.47$517.47
HRTX
HERON THERAPEUTICS, INC. /DE/
Jun 6, 2026
Exercise(M)
Direct
12.5K shares-
HRTX
HERON THERAPEUTICS, INC. /DE/
Apr 30, 2026
Exercise(M)
Direct
11.8K shares-
HRTX
HERON THERAPEUTICS, INC. /DE/
Apr 30, 2026
Exercise(M)
Direct
11.7K shares-
HRTX
HERON THERAPEUTICS, INC. /DE/
Apr 19, 2026
Exercise(M)
Direct
3.9K shares-
HRTX
HERON THERAPEUTICS, INC. /DE/
Jan 31, 2026
Exercise(M)
Direct
11.7K shares-
HRTX
HERON THERAPEUTICS, INC. /DE/
Jan 30, 2026
Award(A)
Performance Stock Units
Direct
188.3K shares-
HRTX
HERON THERAPEUTICS, INC. /DE/
Jan 30, 2026
Award(A)
Restricted Stock Units
Direct
188.3K shares-
HRTX
HERON THERAPEUTICS, INC. /DE/
Jan 19, 2026
Exercise(M)
Direct
3.9K shares-
XAIR
Beyond Air, Inc.
Nov 4, 2025
Disposition(D)
Stock Options (Right to buy)
Direct
1.3K shares-
XAIR
Beyond Air, Inc.
Nov 4, 2025
Award(A)
Stock Options (Right to buy)
Direct
1.3K shares-
XAIR
Beyond Air, Inc.
Nov 4, 2025
Disposition(D)
Stock Options (Right to buy)
Direct
1.3K shares-
XAIR
Beyond Air, Inc.
Nov 4, 2025
Award(A)
Stock Options (Right to buy)
Direct
1.3K shares-
XAIR
Beyond Air, Inc.
Nov 4, 2025
Disposition(D)
Stock Options (Right to buy)
Direct
1.3K shares-
XAIR
Beyond Air, Inc.
Nov 4, 2025
Disposition(D)
Stock Options (Right to buy)
Direct
400 shares-
XAIR
Beyond Air, Inc.
Nov 4, 2025
Award(A)
Stock Options (Right to buy)
Direct
400 shares-
XAIR
Beyond Air, Inc.
Nov 4, 2025
Award(A)
Stock Options (Right to buy)
Direct
1.3K shares-
XAIR
Beyond Air, Inc.
Nov 4, 2025
Disposition(D)
Stock Options (Right to buy)
Direct
1.5K shares-

		Type	Shares	Price		Ownership
Oct 19, 2026	HRTX HERON THERAPEUTICS, INC. /DE/	Exercise(M)	3,874	-	$0	Direct
Oct 19, 2026	HRTX HERON THERAPEUTICS, INC. /DE/	Tax Payment(F)	1,102	$0.36	$397	Direct
Jul 31, 2026	HRTX HERON THERAPEUTICS, INC. /DE/	Tax Payment(F)	3,326	$0.50	$1,663	Direct
Jul 31, 2026	HRTX HERON THERAPEUTICS, INC. /DE/	Exercise(M)	11,694	-	$0	Direct
Jul 30, 2026	HRTX HERON THERAPEUTICS, INC. /DE/	Exercise(M)	11,769	-	$0	Direct
Jul 30, 2026	HRTX HERON THERAPEUTICS, INC. /DE/	Tax Payment(F)	3,348	$0.50	$1,674	Direct
Jul 19, 2026	HRTX HERON THERAPEUTICS, INC. /DE/	Exercise(M)	3,874	-	$0	Direct
Jul 19, 2026	HRTX HERON THERAPEUTICS, INC. /DE/	Tax Payment(F)	1,101	$0.47	$517	Direct
Jun 6, 2026	HRTX HERON THERAPEUTICS, INC. /DE/	Exercise(M)	12,500	-	$0	Direct
Apr 30, 2026	HRTX HERON THERAPEUTICS, INC. /DE/	Exercise(M)	11,770	-	$0	Direct
Apr 30, 2026	HRTX HERON THERAPEUTICS, INC. /DE/	Exercise(M)	11,694	-	$0	Direct
Apr 19, 2026	HRTX HERON THERAPEUTICS, INC. /DE/	Exercise(M)	3,874	-	$0	Direct
Jan 31, 2026	HRTX HERON THERAPEUTICS, INC. /DE/	Exercise(M)	11,695	-	$0	Direct
Jan 30, 2026	HRTX HERON THERAPEUTICS, INC. /DE/	Award(A) Performance Stock Units	188,314	-	-	Direct
Jan 30, 2026	HRTX HERON THERAPEUTICS, INC. /DE/	Award(A) Restricted Stock Units	188,315	-	-	Direct
Jan 19, 2026	HRTX HERON THERAPEUTICS, INC. /DE/	Exercise(M)	3,875	-	$0	Direct
Nov 4, 2025	XAIR Beyond Air, Inc.	Disposition(D) Stock Options (Right to buy)	1,250	-	-	Direct
Nov 4, 2025	XAIR Beyond Air, Inc.	Award(A) Stock Options (Right to buy)	1,250	-	-	Direct
Nov 4, 2025	XAIR Beyond Air, Inc.	Disposition(D) Stock Options (Right to buy)	1,250	-	-	Direct
Nov 4, 2025	XAIR Beyond Air, Inc.	Award(A) Stock Options (Right to buy)	1,250	-	-	Direct
Nov 4, 2025	XAIR Beyond Air, Inc.	Disposition(D) Stock Options (Right to buy)	1,250	-	-	Direct
Nov 4, 2025	XAIR Beyond Air, Inc.	Disposition(D) Stock Options (Right to buy)	400	-	-	Direct
Nov 4, 2025	XAIR Beyond Air, Inc.	Award(A) Stock Options (Right to buy)	400	-	-	Direct
Nov 4, 2025	XAIR Beyond Air, Inc.	Award(A) Stock Options (Right to buy)	1,250	-	-	Direct
Nov 4, 2025	XAIR Beyond Air, Inc.	Disposition(D) Stock Options (Right to buy)	1,500	-	-	Direct

1-25 of 58 transactions

About Forbes William P

Forbes William P (SEC CIK 0001314760) files insider reports with the SEC as EVP, Chief Development Officer of HERON THERAPEUTICS, INC. /DE/ (HRTX) and Director of Beyond Air, Inc. (XAIR).

Signal8 holds 22 ownership filings by Forbes William P, all Form 4s, filed between Oct 21, 2024 and Oct 21, 2026. Those filings report 58 transactions, from Oct 19, 2024 to Oct 19, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Forbes William P's filings is in CARY, NC.

Recent filings by Forbes William P

Oct 19, 2026: Option exercise of HRTX shares (Form 4, code M).
Oct 19, 2026: Tax withholding of HRTX shares (Form 4, code F).
Jul 31, 2026: Tax withholding of HRTX shares (Form 4, code F).
Jul 31, 2026: Option exercise of HRTX shares (Form 4, code M).
Jul 30, 2026: Option exercise of HRTX shares (Form 4, code M).

Other insiders filing for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Duarte Ira, EVP, Chief Financial Officer
Collard Craig A, Chief Executive Officer
Hensley Mark Earl, Chief Operating Officer
Christian Waage, Director
Kaseta Michael, Director
Johnson Craig A, Director

How to read Form 4 transaction codes